TranCelerate conducts survey on standardisation of delegated responsibility forms

The member companies of TransCelerate are working together to develop guidance documents/template forms for the following documents, FDA1571, FDA1572 and Delegation of Authority Forms. The objective of this workstream is to develop these documents to build efficiencies for both sponsor companies and sites.

To ensure these documents are developed with end users in mind, they are asking investigators and other site representatives to complete a short survey, which will help identify the most important issues around completing Delegation of responsibility forms.

TransCelerate was formed in September 2012, when ten leading pharmaceutical companies formed the non-profit organization BioPharma Inc. (TransCelerate), with a focus on accelerating the development of new medicines – initially by identifying ways to make the clinical trial process more efficient.